Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5824769 | Clinical Therapeutics | 2015 | 9 Pages |
Abstract
At the intended dose under fasting conditions, amifampridine exposure may be increased. European Union Drug Regulating Authorities Clinical Trials identifier: 2011-000596-13.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Peter E. PhD, Donald G. PhD, Boyd PhD, Adrian MD, Charles A. PhD,